Rutgers researcher Ubydul Haque co-creates a tool to help identify outbreaks and prioritize virus control efforts. Haque is a principal faculty member of Rutgers Global Health Institute.
Wilfred Ngwa develops technologies that integrate with radiation therapy to improve cancer treatment. He also chairs the Lancet Oncology commission on cancer in sub-Saharan Africa and advises the Biden Administration. He will be a professor of global health and radiation oncology.
A core faculty member of Rutgers Global Health Institute, Rivera explores the roles of culture, community, and communication in public health. For her work related to cancer health disparities in Latino communities, she developed a qualitative research method to study how individuals use social media.
Ubydul Haque conducts data-based research for predicting locations of infectious disease outbreaks and examining climate-related health hazards. He will be an assistant professor of global health with a joint appointment at Rutgers School of Public Health.
A Rutgers University–Newark sociologist has been awarded a $1.9 million grant to evaluate the effects of pandemic eviction-prevention policies on individual and community mortality.
Herrera is a research scientist who studies epidemic viruses and infectious diseases, with a focus on developing diagnostic and therapeutic tools to improve disease outbreak preparedness and response. He is an assistant professor of global health at Rutgers Global Health Institute with joint appointments at Robert Wood Johnson Medical School.
Gwenyth Lee’s research explores the compounding impacts of multiple early-life exposures on child development in low- and middle-income countries. She arrived at Rutgers Global Health Institute in September.
When it comes to global health, there is no off season. This summer, Rutgers faculty, students, and staff have been involved in diverse projects that address health inequities, both in the U.S. and internationally.
Socially disadvantaged children and those from minority backgrounds are less likely to receive services before 36 months of age, a Rutgers study finds.
Understanding the characteristics of the people who use the law is important because it raises questions about whether this end-of-life option is broadly and equitably available, says Rutgers researcher Elissa Kozlov.